The Frequency of GRASP Gene’s Promoter Methylation in Colorectal Cancer Tissue Compared with Healthy Surrounding Tissue

Document Type : Original Article (s)

10.22122/jims.v38i608.13242

Abstract

Background: The colorectal cancer (CRC) is one of the most common cancers. There are several invasive and noninvasive methods for detecting CRC. Diagnosis based on the molecular markers in early stages seems to be a good choice. The aim of present study was evaluating the methylation in GRASP gen promoter in colorectal cancer tissue compared with healthy surrounding tissue.
Methods: This cross-sectional study was performed on 50 patients suffered from CRC during 2016-2019. The DNA was extracted from 50 Formalin-Fixed Paraffin-Embedded (FFPE) samples of CRC tissues in early stages (I and II), and normal surrounding tissues. In paraffin method, methylation-quantification of endonuclease-resistant DNA was calculated, and their frequency were compared in both groups.
Findings: GRASP gene’s promoter was highly methylated in patients with CRC in early stages compared to their normal margins. GRASP gen promoter methylation was 70.47% (P < 0.00001) in CRC tissue compared with 38.08% in normal margin (P < 0.0001).
Conclusion: The results showed that frequency of Grasp gen’s promoter methylation in colorectal cancerous tissue was significantly more than normal surrounding tissue.

Keywords

References

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009; 361(25): 2449-60.
Pritchard CC, Grady WM. Colorectal cancer molecular biology moves into clinical practice. Gut 2011; 60(1): 116-29.
Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R. Epidemiology and molecular genetics of colorectal cancer in Iran: A review. Arch Iran Med 2009; 12(2): 161-9.
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017; 66(4): 683-91.
Schrock A, Leisse A, de VL, Gevensleben H, Droge F, Franzen A, et al. Free-circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients: An observational prospective cohort study. Clin Chem 2017; 63(7): 1288-96.
Ness RM, Holmes AM, Klein R, Dittus R. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol 2000; 95(7): 1800-11.
Fisher JA, Fikry C, Troxel AB. Cutting cost and increasing access to colorectal cancer screening: Another approach to following the guidelines. Cancer Epidemiol Biomarkers Prev 2006; 15(1): 108-13.
Carmona FJ, Azuara D, Berenguer-Llergo A, Fernandez AF, Biondo S, de Oca J, et al. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res (Phila) 2013; 6(7): 656-65.
Wagner PD, Verma M, Srivastava S. Challenges for biomarkers in cancer detection. Ann N Y Acad Sci 2004; 1022: 9-16.
Imperiale TF, Ransohoff DF, Itzkowitz SH. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014; 371(2): 187-8.
Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, et al. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer 2014; 14: 54.
Mahapatra S, Klee EW, Young CY, Sun Z, Jimenez RE, Klee GG, et al. Global methylation profiling for risk prediction of prostate cancer. Clin Cancer Res 2012; 18(10): 2882-95.
Mori Y, Olaru AV, Cheng Y, Agarwal R, Yang J, Luvsanjav D, et al. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocr Relat Cancer 2011; 18(4): 465-78.
Yamada N, Yasui K, Dohi O, Gen Y, Tomie A, Kitaichi T, et al. Genome-wide DNA methylation analysis in hepatocellular carcinoma. Oncol Rep 2016; 35(4): 2228-36.
Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, et al. Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clin Colorectal Cancer 2010; 9(3): 168-76.
Beggs AD, Jones A, El-Bahrawy M, Abulafi M, Hodgson SV, Tomlinson IP. Whole-genome methylation analysis of benign and malignant colorectal tumours. J Pathol 2013; 229(5): 697-704.
Journal of Isfahan Medical School
Volume 38, Issue 608
December 2020
Pages 1043-1047

Files

History

  • Receive Date: 31 March 2022
  • Accept Date: 31 March 2022

Share

How to cite

Statistics